The head of the Food and Drug Administration (FDA) said late Thursday that his agency will move to quickly authorise the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.

Pfizer’s COVID-19 vaccine is entering the final phase of review before the US government decides whether to allow millions to get the shots.